{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Ashfaqul Hoque"}, {"accession": "MS:1000589", "name": "contact email", "value": "ahoque@svi.edu.au"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "St Vincent's Institute of Medical Research (SVI)"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "John W Scott"}, {"accession": "MS:1000589", "name": "contact email", "value": "jscott@svi.edu.au"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Protein Chemistry and Metabolism Unit St Vincent's Institute of Medical Research (SVI) 9 Princes Street Fitzroy, Victoria 3065 Australia"}]}], "datasetFiles": [{"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD020133/F079613_DMSO_Flag-CaMKK2-IP.dat"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD020133/F079621_Forskolin-IBMX treatment_Flag-CaMKK2-IP.dat"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD020133/160722_Ash_MOB_01_DMSO_Flag-CaMKK2-IP.mgf"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD020133/160722_Ash_MOB_01_DMSO_Flag-CaMKK2-IP.raw"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD020133/160722_Ash_MOB_02_Forskolin-IBMX treatmnet_Flag-CaMKK2-IP.mgf"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD020133/160722_Ash_MOB_02_Forskolin-IBMX treatmnet_Flag-CaMKK2-IP.raw"}, {"accession": "MS:1002851", "name": "Other type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD020133/proteins-19986_Ash_MOB_01_DMSO.xls"}, {"accession": "MS:1002851", "name": "Other type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD020133/proteins-19993_Ash_MOB_02_Forskolin-IBMX treatment.xls"}], "description": "The calcium-calmodulin (Ca2+-CaM) dependent protein kinase kinase-2 (CaMKK2) is activated by increases in intracellular Ca2+ and is a key regulator of cellular and wholebody energy metabolism. CaMKK2 inhibition protects against prostate cancer, hepatocellular carcinoma and metabolic derangements induced by a high-fat diet, therefore elucidating the intracellular mechanisms that inactivate CaMKK2 has important therapeutic implications. Here we show that stimulation of cyclic AMP (cAMP)-dependent protein kinase (PKA) signaling in cells inactivates CaMKK2 by phosphorylation of three conserved serine residues. PKA-dependent phosphorylation of Ser495 directly impairs Ca2+-CaM activation, whereas phosphorylation of Ser100 and Ser511 mediate recruitment of 14-3-3 adaptor proteins that hold CaMKK2 in the inactivated state by preventing dephosphorylation of phospho-Ser495. We also report the crystal structure of 14-3-3z bound to a synthetic diphosphorylated peptide that reveals how the canonical (Ser511) and non-canonical (Ser100) 14-3-3 consensus sites on CaMKK2 co-operate to bind 14-3-3 proteins. Our findings provide a detailed mechanistic insight into how cAMP-PKA signaling inactivates CaMKK2 and reveals a pathway to inhibit CaMKK2 with potential for treating human diseases.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/11/PXD020133"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD020133"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD020133"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Calcium-calmodulin (Ca2+-CaM) dependent protein kinase kinase-2 (CaMKK2), cyclic AMP (cAMP), protein kinase A (PKA), 14-3-3 adaptor proteins"}], "modifications": [{"accession": "MOD:00696", "name": "phosphorylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "32913128"}, {"accession": "MS:1002866", "name": "Reference", "value": "Langendorf CG, O'Brien MT, Ngoei KRW, McAloon LM, Dhagat U, Hoque A, Ling NXY, Dite TA, Galic S, Loh K, Parker MW, Oakhill JS, Kemp BE, Scott JW. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins. J Biol Chem. 2020"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "CaMKK2 Inactivation by cAMP-PKA Signaling and 14-3-3 Adaptor Proteins"}